Other reported genetic variations that increase African populations’ susceptibility to prostate cancer include GSTM1, GSTT1, UDP-glucuronosyltransferase, and sulfotransferase in Tunisia and Algeria (179–182). This evidence concerns the gene B3GAT2 and prostate carcinoma.